4.3 Article

High Rates of Pre-exposure Prophylaxis Eligibility and Associated HIV Incidence in a Population With a Generalized HIV Epidemic in Rakai, Uganda

期刊

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/QAI.0000000000002946

关键词

HIV; cohort; HIV prevention; pre-exposure prophylaxis; PrEP; antiretroviral therapy; Africa

资金

  1. National Institute of Allergy and Infectious Diseases [U01AI100031, U01AI075115, R01AI110324, R01AI102939, R01AI128779, R01AI123002, K01AI125086]
  2. Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health [AI001040]
  3. National Cancer Institute, National Institutes of Health [HHSN261200800001E, 75N910D00024, HHSN261201500003I, 75N91019F00131]
  4. President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention [NU2GGH000817]

向作者/读者索取更多资源

This study conducted cross-sectional and cohort analyses using Uganda's national PrEP eligibility tool in the Rakai Community Cohort Study to estimate the prevalence of PrEP eligibility and HIV incidence associated with it. The findings showed that 29% of participants in sub-Saharan Africa met the PrEP eligibility criteria, and those eligible for PrEP had a higher HIV incidence rate.
Background: The utility of using pre-exposure prophylaxis (PrEP) eligibility assessments to identify eligibility in general populations has not been well studied in sub-Saharan Africa. We used the Rakai Community Cohort Study to conduct a cross-sectional analysis to estimate PrEP eligibility and a cohort analysis to estimate HIV incidence associated with PrEP eligibility. Methods: Based on Uganda's national PrEP eligibility tool, we defined eligibility as reporting at least one of the following HIV risks in the past 12 months: sexual intercourse with more than one partner of unknown HIV status; nonmarital sex act without a condom; sex engagement in exchange for money, goods, or services; or experiencing genital ulcers. We used log-binomial and modified Poisson models to estimate prevalence ratios for PrEP eligibility and HIV incidence, respectively. Findings: We identified 12,764 participants among whom to estimate PrEP eligibility prevalence and 11,363 participants with 17,381 follow-up visits and 30,721 person-years (pys) of observation to estimate HIV incidence. Overall, 29% met at least one of the eligibility criteria. HIV incidence was significantly higher in PrEP-eligible versus non-PrEP-eligible participants (0.91/100 pys versus 0.41/100 pys; P < 0.001) and independently higher in PrEP-eligible versus non-PrEP-eligible female participants (1.18/100 pys versus 0.50/100 pys; P < 0.001). Among uncircumcised male participants, HIV incidence was significantly higher in PrEP-eligible versus non-PrEP-eligible participants (1.07/100 pys versus 0.27/100 pys; P = 0.001), but there was no significant difference for circumcised male participants. Interpretation: Implementing PrEP as a standard HIV prevention tool in generalized HIV epidemics beyond currently recognized high-risk key populations could further reduce HIV acquisition and aid epidemic control efforts.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据